Canopy Growth Corp Files 8-K: Officer/Director Changes

Ticker: CGC · Form: 8-K · Filed: 2025-07-09T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

Canopy Growth 8-K: Board and exec changes filed July 9, 2025.

AI Summary

Canopy Growth Corporation filed an 8-K on July 9, 2025, reporting changes in its board of directors and certain officers, along with updates on compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits.

Why It Matters

Changes in corporate leadership and officer compensation can signal shifts in company strategy or financial health, impacting investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, especially if numerous or unexpected, can indicate internal instability or strategic pivots that carry inherent risks.

Key Players & Entities

FAQ

What specific changes were made to Canopy Growth's board of directors or officers?

The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', but the specific names and details are not provided in this excerpt.

What is the primary purpose of this 8-K filing?

The primary purpose is to report current information about significant corporate events, including changes in directors/officers and compensatory arrangements, as well as Regulation FD disclosures and financial statements.

When was this 8-K filing submitted?

The filing was submitted on July 9, 2025.

What is Canopy Growth Corporation's principal executive office address?

The principal executive offices are located at 1 Hershey Drive, Smiths Falls, Ontario, K7A 0A8.

What is Canopy Growth's standard industrial classification?

Canopy Growth's Standard Industrial Classification is MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].

From the Filing

0001104659-25-066600.txt : 20250709 0001104659-25-066600.hdr.sgml : 20250709 20250709090316 ACCESSION NUMBER: 0001104659-25-066600 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 19 CONFORMED PERIOD OF REPORT: 20250709 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250709 DATE AS OF CHANGE: 20250709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Canopy Growth Corp CENTRAL INDEX KEY: 0001737927 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38496 FILM NUMBER: 251112392 BUSINESS ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 BUSINESS PHONE: 855-558-9333 MAIL ADDRESS: STREET 1: 1 HERSHEY DRIVE CITY: SMITH FALLS STATE: A6 ZIP: K7A0A8 8-K 1 tm2520113d1_8k.htm FORM 8-K false 0001737927 Canopy Growth Corp 00-0000000 0001737927 2025-07-09 2025-07-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): July 9, 2025     Canopy Growth Corporation (Exact name of registrant as specified in its charter)     Canada   001-38496   N/A (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   1 Hershey Drive Smiths Falls , Ontario K7A 0A8 (Address of principal executive offices) (Zip Code)   ( 855 ) 558-9333 (Registrant’s telephone number, including area code)   Not Applicable (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Shares, no par value   CGC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company     ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨             Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   Termination of Chief Financial Officer   On July 9, 2025, Canopy Growth Corporation (the “Company”) terminated the employment of its Chief Fin

View on Read The Filing